Ascendis Pharma As Stock Price on February 17, 2024
| ASND Stock | USD 129.67 2.75 2.08% |
Below is the normalized historical share price chart for Ascendis Pharma AS extending back to January 28, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Ascendis Pharma stands at 129.67, as last reported on the 11th of December 2024, with the highest price reaching 133.49 and the lowest price hitting 126.74 during the day.
If you're considering investing in Ascendis Stock, it is important to understand the factors that can impact its price. Ascendis Pharma appears to be very steady, given 3 months investment horizon. Ascendis Pharma AS secures Sharpe Ratio (or Efficiency) of 0.0987, which signifies that the company had a 0.0987% return per unit of standard deviation over the last 3 months. We have found thirty technical indicators for Ascendis Pharma AS, which you can use to evaluate the volatility of the firm. Please makes use of Ascendis Pharma's risk adjusted performance of 0.0557, and Mean Deviation of 1.98 to double-check if our risk estimates are consistent with your expectations.
At present, Ascendis Pharma's Capital Stock is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation is expected to grow to about 70 M, whereas Common Stock Total Equity is forecasted to decline to about 4.2 M. . The current year's Price Earnings To Growth Ratio is expected to grow to 0.79, whereas Price To Sales Ratio is forecasted to decline to 22.84. Ascendis Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 28th of January 2015 | 200 Day MA 135.8086 | 50 Day MA 130.4461 | Beta 0.654 |
Ascendis |
Sharpe Ratio = 0.0987
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ASND | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.07 actual daily | 27 73% of assets are more volatile |
Expected Return
| 0.3 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 7 93% of assets perform better |
Based on monthly moving average Ascendis Pharma is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ascendis Pharma by adding it to a well-diversified portfolio.
Price Book 14.5547 | Enterprise Value Ebitda (20.75) | Price Sales 24.9143 | Shares Float 56.9 M | Wall Street Target Price 191.135 |
Related Headline
89bio Headline on 16th of February 2024
Disposition of 1046 shares by Mansbach Harry H of 89bio at 9... by Mansbach Harry H
Filed transaction by 89bio Inc Officer: Chief Medical Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Ascendis Pharma Valuation on February 17, 2024
It is possible to determine the worth of Ascendis Pharma on a given historical date. On February 17, 2024 Ascendis was worth 145.1 at the beginning of the trading date compared to the closed value of 156.39. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Ascendis Pharma stock. Still, in general, we apply an absolute valuation method to find Ascendis Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Ascendis Pharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Ascendis Pharma's related companies.
| Open | High | Low | Close | Volume | |
| 146.13 | 149.93 | 145.02 | 147.20 | 452,302 | |
02/16/2024 | 145.10 | 156.44 | 145.10 | 156.39 | 507,358 |
| 154.51 | 157.22 | 153.27 | 156.76 | 352,751 |
| Backtest Ascendis Pharma | | | Ascendis Pharma History | | | Ascendis Pharma Valuation | Previous | Next |
Ascendis Pharma Trading Date Momentum on February 17, 2024
| On February 20 2024 Ascendis Pharma AS was traded for 156.76 at the closing time. The top price for the day was 157.22 and the lowest listed price was 153.27 . The trading volume for the day was 352.8 K. The trading history from February 20, 2024 was a factor to the next trading day price growth. The overall trading delta against the next closing price was 0.24% . The overall trading delta against the current closing price is 1.16% . |
Ascendis Pharma AS Fundamentals Correlations and Trends
By evaluating Ascendis Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Ascendis Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Ascendis financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Ascendis Pharma Stock history
Ascendis Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Ascendis is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Ascendis Pharma AS will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Ascendis Pharma stock prices may prove useful in developing a viable investing in Ascendis Pharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 56.3 M | 39.2 M | |
| Net Loss | -524.9 M | -498.6 M |
Ascendis Pharma Stock Technical Analysis
Ascendis Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Ascendis Pharma Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Ascendis Pharma AS cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Ascendis Pharma December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Ascendis Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ascendis Pharma shares will generate the highest return on investment. By undertsting and applying Ascendis Pharma stock market strength indicators, traders can identify Ascendis Pharma AS entry and exit signals to maximize returns
Ascendis Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Ascendis Pharma's price direction in advance. Along with the technical and fundamental analysis of Ascendis Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Ascendis to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0557 | |||
| Jensen Alpha | 0.196 | |||
| Total Risk Alpha | (0.29) | |||
| Sortino Ratio | 0.0376 | |||
| Treynor Ratio | (3.85) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Ascendis Stock analysis
When running Ascendis Pharma's price analysis, check to measure Ascendis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascendis Pharma is operating at the current time. Most of Ascendis Pharma's value examination focuses on studying past and present price action to predict the probability of Ascendis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascendis Pharma's price. Additionally, you may evaluate how the addition of Ascendis Pharma to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Stocks Directory Find actively traded stocks across global markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |